Report
Debbie Wang
EUR 100.00 For Business Accounts Only

LabCorp's 4Q's Dip and Recovery Highlights the Changing Industry Conditions; No Change to Our FVE

Following LabCorp’s fourth-quarter results that slightly exceeded our expectations on revenue growth, but met our estimates on the bottom line, we’re holding steady on our fair value estimate. Considering the various forces buffeting the diagnostic lab industry, we were generally pleased to see organic diagnostic volume rise 1.8% for the full year. The volume decline first seen in October, which led to management revising its outlook lower in November seems to have recovered in December, when ho...
Underlying
Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings is a life sciences company that is focused on guiding patient care. The company reports its business in the following segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). LCD is an independent clinical laboratory business. LCD provides a menu of requested and specialty testing through a network of primary and specialty laboratories across the United States. CDD provides drug development, medical device and diagnostic development solutions from early-stage research to clinical development and commercial market access. CDD engages in early development and clinical trials in each therapeutic category.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch